We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.
CYCLIZINE ANS (Southern XP IP Pty Ltd)
Product name
CYCLIZINE ANS
Sponsor
Date registered
Evaluation commenced
Decision date
Approval time
119 (255 working days)
Active ingredients
cyclizine lactate
Registration type
New generic medicine
Indication
CYCLIZINE ANS is indicated for the prevention of nausea and vomiting in the post-operative period.